Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Amyloid × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Sarcoma 1 Lymphoid 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Esophageal Neoplasms 1 Digestive System Abnormalities 1

Interventions

Oxaliplatin 898 Fluorouracil 729 Capecitabine 670 Gemcitabine 576 Leucovorin 510 Irinotecan 482 Bevacizumab 451 Radiotherapy 419 Cisplatin 384 Drug Therapy 266 Cetuximab 250 Surgical Procedures, Operative 207 Paclitaxel 207 S 1 (combination) 199 Docetaxel 183 pembrolizumab 180 130-nm albumin-bound paclitaxel 173 Nivolumab 170 Sorafenib 163 Radiosurgery 163 apatinib 161 sintilimab 160 Folfox protocol 160 lenvatinib 156 Albumin-Bound Paclitaxel 152 camrelizumab 143 Neoadjuvant Therapy 143 Blood Specimen Collection 142 tislelizumab 138 durvalumab 137

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02530983 2025-04-11

UDD

Mayo Clinic

Gastrointestinal

Digestive System Abnormalities, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡